PAP
Persistent Asset Partners Portfolio holdings
AUM
$114M
This Quarter Return
+1.61%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$117M
AUM Growth
–
Cap. Flow
+$117M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
43.37%
Holding
124
New
96
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Humana
HUM
|
$11.2M |
| 2 |
DaVita
DVA
|
$7.6M |
| 3 |
UnitedHealth
UNH
|
$6.41M |
| 4 |
Pennant Group
PNTG
|
$4.37M |
| 5 |
Cardinal Health
CAH
|
$4.18M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 70% |
| 2 | Financials | 24.42% |
| 3 | Energy | 2.02% |
| 4 | Materials | 1.9% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Relay Therapeutics
RLAY
$709M
| $652K | 0.54% |
+145,828
| New | +$652K |
|
52
Arcus Biosciences
RCUS
$1.24B
| $648K | 0.54% |
+50,213
| New | +$648K |
|
|
CNTA
53
Centessa Pharmaceuticals
CNTA
$2.13B
| $638K | 0.53% |
+37,701
| New | +$638K |
|
54
Cogent Biosciences
COGT
$1.83B
| $630K | 0.52% |
+67,617
| New | +$630K |
|
55
Mr. Cooper
COOP
$12.1B
| $581K | 0.48% |
+5,593
| New | +$581K |
|
56
Crinetics Pharmaceuticals
CRNX
$3.26B
| $531K | 0.44% |
+13,184
| New | +$531K |
|
57
Scholar Rock
SRRK
$3.3B
| $529K | 0.44% |
+13,103
| New | +$529K |
|
58
SmartFinancial
SMBK
$627M
| $526K | 0.44% |
+14,912
| New | +$526K |
|
59
CVB Financial
CVBF
$2.75B
| $518K | 0.43% |
+24,853
| New | +$518K |
|
60
KraneShares CSI China Internet ETF
KWEB
$8.51B
| $514K | 0.43% |
+16,440
| New | +$514K |
|
61
Viridian Therapeutics
VRDN
$1.59B
| $489K | 0.41% |
+25,237
| New | +$489K |
|
|
VBNK
62
VersaBank
VBNK
$369M
| $473K | 0.39% |
+34,178
| New | +$473K |
|
63
Edgewise Therapeutics
EWTX
$1.54B
| $465K | 0.39% |
+16,593
| New | +$465K |
|
64
Towne Bank
TOWN
$2.72B
| $444K | 0.37% |
+12,426
| New | +$444K |
|
65
Synchrony
SYF
$28.1B
| $429K | 0.36% |
+6,214
| New | +$429K |
|
66
Replimune Group
REPL
$460M
| $407K | 0.34% |
+29,103
| New | +$407K |
|
|
SAGE
67
DELISTED
Sage Therapeutics
SAGE
| $389K | 0.32% |
+53,721
| New | +$389K |
|
68
East-West Bancorp
EWBC
$14.7B
| $384K | 0.32% |
+3,727
| New | +$384K |
|
69
Nuvalent
NUVL
$5.74B
| $381K | 0.32% |
+4,435
| New | +$381K |
|
70
UWM Holdings
UWMC
$1.24B
| $375K | 0.31% |
+62,131
| New | +$375K |
|
71
Webster Financial
WBS
$10.3B
| $374K | 0.31% |
+6,211
| New | +$374K |
|
72
KalVista Pharmaceuticals
KALV
$713M
| $374K | 0.31% |
+41,952
| New | +$374K |
|
73
Pfizer
PFE
$141B
| $359K | 0.3% |
+13,530
| New | +$359K |
|
74
VistaGen Therapeutics
VTGN
$113M
| $352K | 0.29% |
+121,651
| New | +$352K |
|
75
First Financial Bancorp
FFBC
$2.48B
| $348K | 0.29% |
+12,422
| New | +$348K |
|